Cargando…
Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney disease
The current understanding of molecular mechanisms driving diabetic kidney disease (DKD) is limited, partly due to the complex structure of the kidney. To identify genes and signalling pathways involved in the progression of DKD, we compared kidney cortical versus glomerular transcriptome profiles in...
Autores principales: | Sembach, Frederikke E., Ægidius, Helene M., Fink, Lisbeth N., Secher, Thomas, Aarup, Annemarie, Jelsing, Jacob, Vrang, Niels, Feldt-Rasmussen, Bo, Rigbolt, Kristoffer T. G., Nielsen, Jens C., Østergaard, Mette V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560499/ https://www.ncbi.nlm.nih.gov/pubmed/34494644 http://dx.doi.org/10.1242/dmm.049086 |
Ejemplares similares
-
Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db/db C57BLKS mice
por: Sembach, Frederikke E., et al.
Publicado: (2019) -
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis
por: Ægidius, Helene M., et al.
Publicado: (2020) -
Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
por: Madsen, Mette Simone Aae, et al.
Publicado: (2019) -
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
por: Tølbøl, Kirstine S, et al.
Publicado: (2018) -
Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH
por: Roth, Jonathan D., et al.
Publicado: (2019)